---
schema_version: "secwatch.filing_event.v1"
accession: "0001601830-23-000075"
form_type: "8-K"
ticker: "RXRX"
cik: "0001601830"
company_name: "RECURSION PHARMACEUTICALS, INC."
filed_at: "2023-12-15T23:59:59+00:00"
generated_at: "2026-06-07T11:56:11.370863+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Recursion registers 3.2M shares of Class A common stock for resale by Tempus Labs

## Summary
- 3,225,902 shares registered for resale by Tempus Labs as payment for initial license fee under Master Agreement.
- Prospectus supplement filed under effective shelf registration statement (Form S-3ASR) on December 15, 2023.
- Shares were originally issued to Tempus in November 2023 per the Master Agreement described in prior Form 8-K.
- Resale offering is exempt from registration under the Securities Act.

## SEC filing metadata
- accession: 0001601830-23-000075
- form_type: 8-K
- ticker: RXRX
- cik: 0001601830
- company_name: RECURSION PHARMACEUTICALS, INC.
- filed_at: 2023-12-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601830/000160183023000075/0001601830-23-000075-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601830/000160183023000075/rxrx-20231215.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601830-23-000075
- JSON: https://secwatch.observer/filing/0001601830-23-000075.json
- Plain text: https://secwatch.observer/filing/0001601830-23-000075.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.